ESC Heart Failure

Papers
(The H4-Index of ESC Heart Failure is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Corrigendum79
75
Right ventricular strain predicts outcome in patients receiving sacubitril/valsartan: A sub‐analysis of DISCOVER‐ARNI65
Prediction of cardiac events with non‐contrast magnetic resonance feature tracking in patients with ischaemic cardiomyopathy65
Establishing a novel model to assess exercise capacity in chronic heart failure based on stress echocardiography63
Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices63
Synchronized diaphragmatic stimulation: a case report of a novel extra‐cardiac intervention for chronic heart failure57
Systolic dysfunction and mortality in critically ill patients: more data are needed to believe in this association!56
Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation56
Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan55
Cardiac involvement in patients recovering from Delta Variant of COVID‐19: a prospective multi‐parametric MRI study52
New insight: particle flow rate from the airways as an indicator of cardiac failure in the intensive care unit47
Impact of age on characteristics, performance measures and outcomes of inpatients for heart failure in Beijing, China45
Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure44
Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome43
Blood perfusion status is important in the prognosis of ventricular aneurysm complicated by ventricular septal rupture43
Editors' highlight picks from 2023 in ESC heart failure43
Heart failure and trimethylamine N‐oxide: time to transform a ‘gut feeling’ in a fact?42
Models of cardiovascular surgery biobanking to facilitate translational research and precision medicine42
Characteristics and management of very elderly patients with heart failure: a retrospective, population cohort study41
Effect of beta‐blockade on mortality in patients with cardiac amyloidosis: A systematic review and meta‐analysis41
Atrial fibrillation ablation in patients with arrhythmia‐induced cardiomyopathy: a prospective multicentre study40
Acylation‐stimulating protein and heart failure progression in arrhythmogenic right ventricular cardiomyopathy40
The use of MitraClip for nonobstructive hypertrophic cardiomyopathy with mixed severe mitral valve regurgitation39
Systemic immune‐inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction39
Serum angiotensin‐converting enzyme levels indicating early sarcoidosis diagnosis and immunosuppressive therapy efficacy39
Discordance between estimated and measured changes in plasma volume among patients with acute heart failure39
Issue Information38
Burden of hospitalizations in newly diagnosed heart failure patients in Poland: real world population based study in years 2013–201938
Real‐time pulmonary artery pressure monitoring in heart failure patients: an updated cost‐effectiveness analysis38
Cardiogenic shock requiring VA‐ECMO therapy in scorpionism‐induced myocarditis37
Uncovering the genetic links of SARS‐CoV‐2 infections on heart failure co‐morbidity by a systems biology approach36
Sex differences in the impact of frailty on patients with heart failure: A retrospective cohort study36
Circ_0001206 regulates miR‐665/CRKL axis to alleviate hypoxia/reoxygenation‐induced cardiomyocyte injury in myocardial infarction36
Predictive value of global longitudinal strain by left ventricular ejection fraction36
Intense optimization of oral therapy rapidly restores respiratory function in worsening heart failure patients36
0.11312699317932